Transfusion-related acute lung injury

Current Opinion in Hematology

Volumn 12, Issue 6, 2005, Pages 480-487

  Webert, Kathryn E ^a   Blajchman, Morris A ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Lung injury; Pulmonary edema; Respiratory distress; Transfusion reaction; Transfusion related acute lung injury

Indexed keywords

AUTOANTIBODY; BRAIN NATRIURETIC PEPTIDE; CD16 ANTIGEN; CD32 ANTIGEN; CD64 ANTIGEN; CORTICOSTEROID; ENDOTOXIN ANTIBODY; GRANULOCYTE ANTIBODY; HLA ANTIBODY; HLA ANTIGEN; HLA DR ANTIGEN; NONSTEROID ANTIINFLAMMATORY AGENT; PENTOXIFYLLINE; PROSTAGLANDIN E1; SURFACTANT; TUMOR NECROSIS FACTOR ANTIBODY;

ACUTE DISEASE; ANTIBODY DETECTION; ANTIGEN ANTIBODY COMPLEX; BLOOD; BLOOD DONOR; BLOOD STORAGE; BLOOD TRANSFUSION; CAUSE OF DEATH; CLINICAL FEATURE; CONSENSUS; DISEASE CLASSIFICATION; DYSPNEA; ERYTHROCYTE TRANSFUSION; FEVER; FRACTIONATION; HEALTH CARE ORGANIZATION; HUMAN; HYPOTENSION; IMMUNOPATHOLOGY; LABORATORY TEST; LUNG EDEMA; MULTIPARA; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TRANSFUSION RELATED ACUTE LUNG INJURY;

BLOOD TRANSFUSION; HUMANS; PULMONARY EDEMA; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 27544508465     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/01.moh.0000177829.85904.39     Document Type: Review

References (96)

1. Webert KE, Blajchman MA. Transfusion-related acute lung injury. Transfus Med Rev 2003; 17:252-262.
2. Kleinman S, Caulfield T, Chan P, et al. Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel. Transfusion 2004; 44:1774-1789. This is the statement of the Consensus Panel of the Canadian Consensus Conference 'Towards an Understanding of TRALI' held in Toronto, Canada in April 2004. The Consensus Panel discussed important issues including the need for a standardized definition of TRALI.
3. Goldman M, Webert KE, Arnold DM, et al. Proceedings of a consensus conference: towards an understanding of TRALI. Transfus Med Rev 2005; 19:2-31. This article reports the proceedings of the Canadian Consensus Conference 'Towards an Understanding of TRALI' held in Toronto, Canada in April 2004, which summarizes the presentations of the invited panel of experts.
4. Toy P, Popovsky MA, Abraham E, et al. Transfusion-related acute lung injury: definition and review. Crit Care Med 2005; 33:721-726. This is the statement of the National Heart, Lung and Blood Institute Working Group on TRALI. It presents a discussion of a possible definition of TRALI and the mechanisms of TRALI.
5. Williamson LM. Transfusion hazard reporting: powerful data, but do we know how best to use it? Transfusion 2002; 42:1249-1252.
6. Gajic O, Moore SB. Transfusion-related acute lung injury. Mayo Clin Proc 2005; 80:766-770.
7. Bux J. Transfusion-related acute lung injury (TRALI): a serious adverse event of blood transfusion. Vox Sang 2005; 89:1-10.
8. Bernard GR, Artigas A, Brigham KL, et al. Report of the American-European Consensus conference on acute respiratory distress syndrome: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Consensus Committee. J Crit Care 1994; 9:72-81.
9. Popovsky MA, Moore SB. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion 1985; 25:573-577.
10. Kopko PM, Popovsky MA, MacKenzie MR, et al. HLA class II antibodies in transfusion-related acute lung injury. Transfusion 2001; 41:1244-1248.
11. Weber JG, Warner MA, Moore SB. What is the incidence of perioperative transfusion-related acute lung injury? Anesthesiology 1995; 82:789.
12. Popovsky MA, Chaplin HC Jr, Moore SB. Transfusion-related acute lung injury: a neglected, serious complication of hemotherapy. Transfusion 1992; 32:589-592.
13. Silliman CC, Boshkov LK, Mehdizadehkashi Z, et al. Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood 2003; 101:454-462.
14. Silliman CC, Ambruso DR, Boshkov LK. Transfusion-related acute lung injury. Blood 2005; 105:2266-2273. This is a review that summarizes the clinical presentation, treatment, differential diagnosis, epidemiology, pathogenesis and prevention of TRALI.
15. Stainsby D, Williamson L, Jones H, Cohen H.6 Years of shot reporting: its influence on UK blood safety. Transfus Apheresis Sci 2004; 31:123-131. This report reviews the data collected during the first 6 years of the Serious Hazards of Transfusion (SHOT) scheme and discusses how the data have provided evidence to support the development of blood safety strategies in the UK.
16. Popovsky MA. Transfusion-related acute lung injury (TRALI). In: Popovsky MA, editor. Transfusion reactions, edn 2. Bethesda, MD: AABB Press; 2001. pp. 155-170.
17. Engelfriet CP, Reesink HW, Brand A, et al. Transfusion-related acute lung injury (TRALI). Vox Sang 2001; 81:269-283.
18. Holness L, Knippen MA, Simmons L, Lachenbruch PA. Fatalities caused by TRALI. Transfus Med Rev 2004; 18:184-188. This article provides a retrospective review of fatalities caused by TRALI over a 5-year period (1997-2002) that were reported to the Center for Biologics Evaluation and Research.
19. Boshkov L, Silliman C, Clarke G, et al. Transfusion related acute lung injury (TRALI) following platelet transfusion: a study of possible etiologic factors. Blood 1995; 86:1403.
20. Yost CS, Matthay MA, Gropper MA. Etiology of acute pulmonary edema during liver transplantation: a series of cases with analysis of the edema fluid. Chest 2001; 119:219-223.
21. Distenfeld A. Transfusion-related acute lung injury. JAMA 2002; 288:316.
22. Cooling L. Transfusion-related acute lung injury. JAMA 2002; 288:315-316.
23. Stainsby D, Cohen H, Jones H, et al, for the SHOT Steering Committee. Serious Hazards of Transfusion (SHOT) Annual Report 2003. Serious Hazards of Transfusion Office, Manchester Blood Office, 2004.
24. Roffey P, Thangathurai D, Mikhail M, et al. TRALI and massive transfusion. Resuscitation 2003; 58:121.
25. Silliman CC. Transfusion-related acute lung injury. Transfus Med Rev 1999; 13:177-186.
26. Medeiros BC, Kogel KE, Kane MA. Transfusion-related acute lung injury (TRALI) following platelet transfusion in a patient receiving high-dose interleukin-2 for treatment of metastatic renal cell carcinoma. Transfus Apheresis Sci 2003; 29:25-27.
27. Gajic O, Rana R, Mendez JL, et al. Acute lung injury after blood transfusion in mechanically ventilated patients. Transfusion 2004; 44:1468-1474. This retrospective cohort study investigated the risk of ALI in 181 mechanically ventilated patients receiving blood transfusions. The authors concluded that thrombocytopenia and transfusion of fresh frozen plasma, but not storage age of red blood cells, were associated with the development of ALI.
28. Silliman CC, Paterson AJ, Dickey WO, et al. The association of biologically active lipids with the development of transfusion-related acute lung injury: a retrospective study. Transfusion 1997; 37:719-726.
29. Lucas G, Rogers S, Evans R, et al. Transfusion-related acute lung injury associated with interdonor incompatibility for the neutrophil-specific antigen HNA-1a. Vox Sang 2000; 79:112-115
30. Popovsky MA. Transfusion-related acute lung injury. Transfusion 1995; 35:180-181.
31. Popovsky MA. Transfusion-related acute lung injury. Curr Opin Hematol 2000; 7:402-407.
32. Rizk A, Gorson KC, Kenney L, Weinstein R. Transfusion-related acute lung injury after the infusion of IVIG. Transfusion 2001; 41:264-268.
33. Urahama N, Tanosaki R, Masahiro K, et al. TRALI after the infusion of marrow cells in a patient with acute lymphoblastic leukemia. Transfusion 2003; 43:1553-1557.
34. Covin RB, Ambruso DR, England KM, et al. Hypotension and acute pulmonary insufficiency following transfusion of autologous red blood cells during surgery: a case report and review of the literature. Transfus Med 2004; 14:375-383. This is an interesting case report of a case of TRALI that occurred after the transfusion of autologous RBCs.
35. Sachs UJ, Bux J. TRALI after the transfusion of cross-match-positive granulocytes. Transfusion 2003; 43:1683-1686.
36. Flesch BK, Neppert J. Transfusion-related acute lung injury caused by human leucocyte antigen class II antibody. Br J Haematol 2002; 116:673-676.
37. Davoren A, Curtis BR, Shulman IA, et al. TRALI due to granulocyte-agglutinating human neutrophil antigen-3a (5b) alloantibodies in donor plasma: a report of 2 fatalities. Transfusion 2003; 43:641-645.
38. Ward HN. Pulmonary infiltrates associated with leukoagglutinin transfusion reactions. Ann Intern Med 1970; 73:689-694.
39. Nakagawa M, Toy P. Acute and transient decrease in neutrophil count in transfusion related acute lung injury: cases at one hospital. Transfusion 2004; 44:1689-1694. This report describes two cases of TRALI both associated with a decrease in neutrophil count. This represents a previously unrecognized feature of TRALI and may yield new insights into the pathophysiology of TRALI.
40. Popovsky MA, Davenport RD. Transfusion-related acute lung injury: femme fatale? Transfusion 2001; 41:312-315.
41. Bux J, Becker F, Seeger W, et al. Transfusion-related acute lung injury due to HLA-A2-specific antibodies in recipient and NB1-specific antibodies in donor blood. Br J Haematol 1996; 93:707-713.
42. Clay ME, Stroncek DF. Granulocyte immunology. In: Anderson KC, Ness PM, editors. Scientific basis of transfusion medicine: implications for clinical practice. Philadelphia: WB Saunders: 2000. pp. 180-206.
43. Carilli AD, Ramanamurty MV, Chang YS, et al. Noncardiogenic pulmonary edema following blood transfusion. Chest 1978; 74:310-312.
44. McCullough J, Clay M, Hurd D, et al. Effect of leukocyte antibodies and HLA matching on the intravascular recovery, survival, and tissue localization of 111-indium granulocytes. Blood 1986; 67:522-528.
45. Seeger W, Schneider U, Kreusler B, et al. Reproduction of transfusion-related acute lung injury in an ex vivo lung model. Blood 1990; 76:1438-1444.
46. Andrews AT, Zmijewski CM, Bowman HS, Reihart JK. Transfusion reaction with pulmonary infiltration associated with HL-A-specific leukocyte antibodies. Am J Clin Pathol 1976; 66:483-487
47. Popovsky MA, Abel MD, Moore SB. Transfusion-related acute lung injury associated with passive transfer of antileukocyte antibodies. Am Rev Respir Dis 1983; 128:185-189.
48. Eastlund T, McGrath PC, Britten A, Propp R. Fatal pulmonary transfusion reaction to plasma containing donor HLA antibody. Vox Sang 1989; 57:63-66.
49. Florell SR, Velasco SE, Fine PG. Perioperative recognition, management, and pathologic diagnosis of transfusion-related acute lung injury. Anesthesiology 1994; 81:508-510.
50. Virchis AE, Contreras M, Navarrete C, et al. Transfusion-related acute lung injury (TRALI) due to inter-donor incompatibility. Blood 1996; 88:2114.
51. Dry SM, Bechard KM, Milford EL, et al. The pathology of transfusion-related acute lung injury. Am J Clin Pathol 1999; 112:216-221.
52. Varela M, Mas A, Nogues N, et al. TRALI associated with HLA class II antibodies. Transfusion 2002; 42:1102.
53. Kao GS, Wood IG, Dorfman DM, et al. Investigations into the role of anti-HLA class II antibodies in TRALI. Transfusion 2003; 43:185-191.
54. Win N, Brown C, Navarrete C. TRALI associated with HLA class II antibodies Transfusion 2003; 43:545-546.
55. Dooren MC, Ouwehand WH, Verhoeven AJ, et al. Adult respiratory distress syndrome after experimental intravenous gamma-globulin concentrate and monocyte-reactive IgG antibodies. Lancet 1998; 352:1601-1602.
56. Paglieroni TG, Kopko PM, Popovsky MA, et al. Monocyte antibody associated with transfusion related acute lung injury (TRALI). Blood 2001; 98:57A.
57. Saigo K, Sugimoto T, Tone K, et al. Transfusion-related acute lung injury in a patient with acute myelogenous leukaemia having anti-IgA2m(1) antibody. J Int Med Res 1999; 27:96-100.
58. Santamaria A, Moya F, Martinez C, et al. Transfusion-related acute lung injury associated with an NA1-specific antigranulocyte antibody. Haematologica 1998; 83:951-952
59. Yomtovian R, Kline W, Press C, et al. Severe pulmonary hypersensitivity associated with passive transfusion of a neutrophil-specific antibody. Lancet 1984; 1:244-246.
60. Nordhagen R, Conradi M, Dromtorp SM. Pulmonary reaction associated with transfusion of plasma containing anti-5b. Vox Sang 1986; 51:102-107.
61. Zupanska B, Uhrynowska M, Konopka L. Transfusion-related acute lung injury due to granulocyte-agglutinating antibody in a patient with paroxysmal nocturnal hemoglobinuna. Transfusion 1999: 39:944-947.
62. Van Buren NL, Stroncek DF, Clay ME, et al. Transfusion-related acute lung injury caused by an NB2 granulocyte-specific antibody in a patient with thrombotic thrombocytopenic purpura. Transfusion 1990; 30:42-45.
63. Loger R, Palm S, Wulf H, et al. Transfusion-related lung injury with leukopenic reaction caused by fresh frozen plasma containing anti-NB1. Anesthesiology 1999; 91:1529-1532.
64. Dykes A, Smallwood D, Kotsimbos T, Street A. Transfusion-related acute lung injury (TRALI) in a patient with a single lung transplant. Br J Haematol 2000; 109:674-676.
65. Engelfriet CP, Reesink HW. Transfusion-related acute lung injury (TRALI). Vox Sang 2001; 81:269-270
66. Boshkov L, Mehdizadehkashi Z, Alcorn J, et al. Failure to implicate antigranulocyte or anti-HLA class I or class II antibodies as the major pathogenetic mechanism in a series of transfusion associated acute lung injury cases (TRALI) (abstract). Blood 2001; 98:828a.
67. Silliman CC, Clay KL, Thurman GW, et al. Partial characterization of lipids that develop during the routine storage of blood and prime the neutrophil NADPH oxidase. J Lab Clin Med 1994; 124:684-694.
68. Silliman CC, Dickey WO, Paterson AJ, et al. Analysis of the priming activity of lipids generated during routine storage of platelet concentrates. Transfusion 1996; 36:133-139.
69. Silliman CC, Voelkel NF, Allard JD, et al. Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model. J Clin Invest 1998; 101:1458-1467
70. Lenahan SE, Domen RE, Silliman CC, et al. Transfusion-related acute lung injury secondary to biologically active mediators. Arch Pathol Lab Med 2001; 125:523-526.
71. Silliman CC, Thurman GW, Ambruso DR. Stored blood components contain agents that prime the neutrophil NADPH oxidase through the platelet-activating- factor receptor. Vox Sang 1992; 63:133-136.
72. Silliman CC, Bjornsen AJ, Wyman TH, et al. Plasma and lipids from stored platelets cause acute lung injury in an animal model. Transfusion 2003; 43:633-640.
73. Salzer WL, McCall CE. Primed stimulation of isolated perfused rabbit lung by endotoxin and platelet activating factor induces enhanced production of thromboxane and lung injury. J Clin Invest 1990; 85:1135-1143.
74. Rabinovici R, Esser KM, Lysko PG, et al. Priming by platelet-activating factor of endotoxin-induced lung injury and cardiovascular shock. Circ Res 1991; 69:12-25.
75. Downey GP, Doherty DE, Schwab B III, et al. Retention of leukocytes in capillaries: role of cell size and deformability. J Appl Physiol 1990; 69:1767-1778.
76. Burgher AH, Aslan D, Laudi N, Bowman RJ. Use of brain natriuretic peptide to evaluate transfusion-related acute lung injury. Transfusion 2004; 44:1533-1534.
77. Wu TJ, Teng RJ, Tsou Yau KI. Transfusion-related acute lung injury treated with surfactant in a neonate. Eur J Pediatr 1996; 155:589-591.
78. Nouraei SM, Wallis JP, Bolton D, Hasan A. Management of transfusion-related acute lung injury with extracorporeal cardiopulmonary support in a four-year-old child. Br J Anaesth 2003; 91:292-294.
79. Wolf CF, Canale VC. Fatal pulmonary hypersensitivity reaction to HL-A incompatible blood transfusion: report of a case and review of the literature. Transfusion 1976; 16:135-140.
80. Rebibo D, Hauser L, Slimani A, et al. The French Haemovigilance System: organization and results for 2003. Transfus Apheresis Sci 2004; 31:145-153.
81. Kopko PM, Marshall CS, MacKenzie MR, et al. Transfusion-related acute lung injury: report of a clinical look-back investigation. JAMA 2002; 287:1968-1971.
82. Nicolle AL, Chapman CE, Carter V, Wallis JP. Transfusion-related acute lung injury caused by two donors with anti-human leucocyte antigen class II antibodies: a look-back investigation. Transfus Med 2004; 14:225-230. This is a lookback investigation of two donors implicated in TRALI who were identified as having HLA type II alloantibodies. Eighteen patients were identified as having received a blood component transfusion from one of the two donors. One of the recipients had evidence of a TRALI reaction, previously undiagnosed.
83. Toy P, Hollis-Perry KM, Jun J, Nakagawa M. Recipients of blood from a donor with multiple HLA antibodies: a lookback study of transfusion-related acute lung injury. Transfusion 2004; 44:1683-1688.
84. Win N, Ranasinghe E, Lucas G. Transfusion-related acute lung injury: a 5-year look-back study. Transfus Med 2002; 12:387-389.
85. Vives J, Gelabert A, Castillo R. HLA antibodies and period of gestation: decline in frequency of positive sera during last trimester. Tissue Antigens 1976; 7:209-212.
86. Morin-Papunen L, Tiilikainen A, Hartikainen-Sorri AL, Maternal HLA immunization during pregnancy: presence of anti HLA antibodies in half of multigravidous women. Med Biol 1984; 62:323-325.
87. Densmore TL, Goodnough LT, Ali S, et al. Prevalence of HLA sensitization in female apheresis donors. Transfusion 1999; 39:103-106.
88. Palfi M, Berg S, Ernerudh J, Berlin G. A randomized controlled trial of transfusion-related acute lung injury: is plasma from multiparous blood donors dangerous? Transfusion 2001; 41:317-322.
89. Kopko PM, Holland PV. Transfusion-related acute lung injury. Br J Haematol 1999; 105:322-329.
90. Bray RA, Harris SB, Josephson CD, et al. Unappreciated risk factors for transplant patients: HLA antibodies in blood components. Hum Immunol 2004; 65:240-244. This study tested 77 units of FFP, 66 units of cryoprecipitate, 106 units of RBCs, and 59 units of apheresis platelets for class I and class II HLA antibodies. Approximately 22% of blood components tested contained alloantibodies.
91. Win N, Montgomery J, Sage D, et al. Recurrent transfusion-related acte lung injury. Transfusion 2001; 41:1421-1425.
92. Wallis JP, Dzik S. Is fresh frozen plasma overtransfused in the United States? Transfusion 2004; 44:1674-1675.
93. Sinnott P, Bodger S, Gupta A, Brophy M. Presence of HLA antibodies in single-donor-derived fresh frozen plasma compared with pooled, solvent detergent-treated plasma (Octaplas). Eur J Immunogenet 2004; 31:271-274.
94. Campbell DA Jr, Swartz RD, Waskerwitz JA, et al. Leukoagglutination with interstitial pulmonary edema. A complication of donor-specific transfusion. Transplantation 1982; 34:300-301.
95. Goeken NE, Schulak JA, Nghiem DD, et al. Transfusion reactions in donor-specific blood transfusion patients resulting from transfused maternal antibody. Transplantation 1984; 38:306-307.
96. Yang X, Ahmed S, Chandrasekaran V. Transfusion-related acute lung injury resulting rom designated blood transfusion between mother and child: a report of two cases. Am J Clin Pathol 2004; 121:590-592. This article reports two cases of TRALI resulting from a designated blood transfusion between mother and child. This represents a situation potentially associated with increased risk of TRALI, because mothers may have developed antibodies to antigens on fetal leukocytes during the pregnancy.